IL220513A - A cutaneous smear preparation that includes and uses calipotriol - Google Patents

A cutaneous smear preparation that includes and uses calipotriol

Info

Publication number
IL220513A
IL220513A IL220513A IL22051312A IL220513A IL 220513 A IL220513 A IL 220513A IL 220513 A IL220513 A IL 220513A IL 22051312 A IL22051312 A IL 22051312A IL 220513 A IL220513 A IL 220513A
Authority
IL
Israel
Prior art keywords
calcipotriol
composition
cutaneous application
cutaneous
application
Prior art date
Application number
IL220513A
Other languages
English (en)
Hebrew (he)
Other versions
IL220513A0 (en
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of IL220513A0 publication Critical patent/IL220513A0/en
Publication of IL220513A publication Critical patent/IL220513A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL220513A 2009-12-22 2012-06-19 A cutaneous smear preparation that includes and uses calipotriol IL220513A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2009/000266 WO2011076206A1 (fr) 2009-12-22 2009-12-22 Composition pharmaceutique comprenant un analogue de la vitamine d et un mélange cosolvant-tensioactif

Publications (2)

Publication Number Publication Date
IL220513A0 IL220513A0 (en) 2012-08-30
IL220513A true IL220513A (en) 2016-05-31

Family

ID=44194970

Family Applications (1)

Application Number Title Priority Date Filing Date
IL220513A IL220513A (en) 2009-12-22 2012-06-19 A cutaneous smear preparation that includes and uses calipotriol

Country Status (13)

Country Link
EP (1) EP2515912A4 (fr)
JP (1) JP5548275B2 (fr)
CN (1) CN102770143B (fr)
AU (1) AU2009357263B2 (fr)
BR (1) BR112012015447A2 (fr)
CA (1) CA2785249A1 (fr)
HK (1) HK1177695A1 (fr)
IL (1) IL220513A (fr)
MX (1) MX2012007227A (fr)
NZ (1) NZ601002A (fr)
RU (1) RU2500387C1 (fr)
WO (1) WO2011076206A1 (fr)
ZA (1) ZA201204619B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107643354B (zh) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 卡泊三醇起始原料a及相关杂质的分离与测定方法
CN106265511A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种性能优异的卡泊三醇倍他米松自微乳制剂
CN106265485A (zh) * 2016-08-22 2017-01-04 江苏知原药业有限公司 一种稳定性改善的卡泊三醇组合物
CN106344589B (zh) * 2016-11-10 2019-11-26 江苏知原药业有限公司 一种稳定性改善的卡泊三醇倍他米松组合物
CN108904445A (zh) * 2018-08-06 2018-11-30 江苏知原药业有限公司 钙泊三醇纳米悬浮液
WO2022040773A1 (fr) * 2020-08-26 2022-03-03 Canadian Nano Pharmaceutical Technology Inc. Compositions à base de nanoémulsion, leurs procédés de préparation et leur utilisation dans l'administration d'ingrédients actifs
CN115350151B (zh) * 2022-09-29 2023-09-12 湖北欣泽霏药业有限公司 一种高稳定性阿法骨化醇液体口服制剂及其制备方法
CN116473985A (zh) * 2023-03-29 2023-07-25 暨南大学 一种多烯类抗真菌药物组合物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763426A (en) * 1993-01-15 1998-06-09 Leo Pharmaceutical Products Ltd. Crystalline form of a vitamin D analogue
JP3340310B2 (ja) * 1996-03-28 2002-11-05 株式会社資生堂 複合エマルジョンおよびその製造方法
WO1999029326A1 (fr) * 1997-12-09 1999-06-17 Chugai Seiyaku Kabushiki Kaisha Emulsions contenant des derives de vitamine d¿3?
EP1051974A4 (fr) * 1997-12-09 2001-09-12 Chugai Pharmaceutical Co Ltd Lotions contenant des derives de vitamine d 3
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6537980B1 (en) * 1999-04-23 2003-03-25 Leo Pharmaceutical Products Ltd. Vitamin D analogues and their pharmaceutical use
JP2001025359A (ja) * 1999-07-15 2001-01-30 Mitsubishi-Kagaku Foods Corp Ｏ／ｗ／ｏ型エマルジョン組成物およびその製造方法
AU2006256860B2 (en) * 2005-06-10 2012-04-19 Galderma S.A. Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent
WO2006138056A1 (fr) * 2005-06-15 2006-12-28 Apollo Pharmaceutical, Inc. Composition pharmaceutique comprenant de l’extrait de mahonia aquifolium pour le traitement du psoriasis
FR2893847B1 (fr) * 2005-11-30 2010-10-29 Galderma Sa Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
JP4913487B2 (ja) * 2006-07-07 2012-04-11 ポーラ化成工業株式会社 使用感に特徴のある化粧料
FR2909284B1 (fr) * 2006-11-30 2012-09-21 Galderma Sa Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
FR2911781B1 (fr) * 2007-01-26 2009-03-20 Fabre Pierre Dermo Cosmetique Emulsion dermatologique et procede de preparation
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970049A1 (fr) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Composition topique du type polyaphron avec de la vitamine D et un corticosteroide

Also Published As

Publication number Publication date
CA2785249A1 (fr) 2011-06-30
EP2515912A1 (fr) 2012-10-31
IL220513A0 (en) 2012-08-30
BR112012015447A2 (pt) 2016-03-15
CN102770143A (zh) 2012-11-07
RU2500387C1 (ru) 2013-12-10
ZA201204619B (en) 2013-09-25
CN102770143B (zh) 2014-11-05
AU2009357263B2 (en) 2015-04-09
HK1177695A1 (en) 2013-08-30
AU2009357263A1 (en) 2012-07-19
JP5548275B2 (ja) 2014-07-16
WO2011076206A1 (fr) 2011-06-30
MX2012007227A (es) 2012-07-30
EP2515912A4 (fr) 2013-12-25
NZ601002A (en) 2014-09-26
JP2013515017A (ja) 2013-05-02

Similar Documents

Publication Publication Date Title
HUE059796T2 (hu) PSMA-t célzó vegyületek és alkalmazásaik
PL2435503T3 (pl) Emulsje na bazie związków hydroksylowych niosących grupy silylowe
PL2652025T3 (pl) Kompozycja powlekająca i jej zastosowanie
PL3480273T3 (pl) Kompozycje klejowe i ich zastosowanie
EP2412789A4 (fr) Composition de lubrifiant et son utilisation
EP2563130A4 (fr) Composition pesticide et utilisation associée
EP2511333A4 (fr) Composition de caoutchouc et utilisations de celle-ci
IL220513A (en) A cutaneous smear preparation that includes and uses calipotriol
ZA201106299B (en) Composition comprising caftaric acid and/or derivatives thereof
EP2501697A4 (fr) Composés de benzoimidazole et utilisations de ceux-ci
EP2402429A4 (fr) Bactérie produisant de l'équol et son utilisation
EP2563131A4 (fr) Composition pesticide et utilisation associée
PL2521445T3 (pl) Preparat i jego zastosowanie
GB0902429D0 (en) Compositions and their use
GB0908174D0 (en) Steroid containing composition and uses thereof
EP2410017A4 (fr) Composition et élément l'utilisant
GB0902173D0 (en) Compounds and their use
GB0909768D0 (en) Novel compounds and uses thereof
EP2615094A4 (fr) Composés de sesterterpène et leur utilisation
GB0922510D0 (en) Compound and use
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
SI2246181T1 (sl) Kompozitni material in njegova uporaba
GB2461611B (en) Composition and use thereof
EP2488179A4 (fr) Inhibiteurs de nrf2 et utilisations de ceux-ci
GB0909792D0 (en) Composition and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees